Navigation Links
Scientists Gather to Discuss Novel Uses of Caliper Life Sciences' Discovery Platforms and Technology
Date:6/29/2009

- Recent 'Innovation for Experimentation' Series Attracts Over 350 Attendees -

HOPKINTON, Mass., June 29 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, reports that more than 350 customers recently attended its "Innovation for Experimentation" seminar series and open house events held in California and Massachusetts. The seminar series showcased how customers were successfully deploying technologies from Caliper to accelerate drug discovery research.

The events were held in San Francisco, San Diego and Hopkinton to discuss the importance of Caliper's automation, microfluidics, and in vivo imaging technologies. Key themes included approaches for obtaining higher fidelity data that better predict human outcomes, increasing throughput and unattended run time while being cognizant of optimizing higher order workflows, decentralizing testing to ensure information is available in real time to decision makers, and increasing the knowledge generated per dollar, hour, and number of samples.

"The life sciences industry is tasked with the noble mission of finding cures and treatments for the sick and suffering," said Kevin Hrusovsky, CEO of Caliper Life Sciences. "Our symposium series 'Innovation for Experimentation' enables us to better align our internal research priorities and investments with customer requirements to ensure that we develop technologies that enable our customers to be successful in increasing the quality and length of life. This year's series was the best attended in years primarily due to our new comprehensive suite of 'breakthrough' LabChip, IVIS and Zephyr platforms."

The events featured customer presentations focused on the adoption of Caliper platforms to accelerate discovery research at the following institutions: Pfizer, Merck, EMD Serono, Amgen, ArQule, Dana Farber Cancer Institute, Boehringer-Ingelheim, Wyeth, Calloway Labs, University of Massachusetts, Genencor, Bristol-Myers Squibb, XcellereX, SUNY Upstate, Vertex, Dow Biopharma, Symbiosis, MacroGenics, Geron, Elan, Roche, and the National Cancer Institute. The open house event in Hopkinton featured a keynote presentation from Kevin Hrusovsky, which is available online: http://www.caliperls.com/investors/open-house-061909-ceo-presentation.php.

Investors and analysts were also invited to attend and participate in a separate breakout session featuring presentations by Kevin Hrusovsky, President and CEO, as well as several members of Caliper's executive team, who outlined Caliper's strategic priorities and the future direction of Caliper's technologies and services. A webcast of this breakout session is available online: http://phx.corporate-ir.net/phoenix.zhtml?c=85833&p=irol-EventDetails&EventId=2268770.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, LabChip, IVIS, and Zephyr are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates ... vital new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse ... from intimate abuse. To support all those victimized by the fear of violence in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... EAST NORRITON, Pa. , Feb. 8, 2016 ... acquisition of November Research Group (NRG),s pharmacovigilance ... of pharmacovigilance system-related consulting services and an Oracle ... regulatory compliance services to Life Sciences companies. ... acquisition strengthens and expands HighPoint,s life sciences capabilities ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016  As part of ... has announced today the appointment of Lori Chmura ... than 20 years in the industry, Chmura,s extensive experience in ... the advancement of Dune Medical Devices. ... will be responsible for leading all sales, marketing and operational ...
(Date:2/8/2016)... Velano Vascular, a medical technology company transforming ... their practitioners, announced today that the company has raised ... the proceeds from this financing, an extension of a ... to support the development and commercialization of the company,s ... Philadelphia , and a number ...
Breaking Medicine Technology: